Unknown

Dataset Information

0

SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass.


ABSTRACT: Increased expression of SIRT1 extends the lifespan of lower organisms and delays the onset of age-related diseases in mammals. Here, we show that SRT2104, a synthetic small molecule activator of SIRT1, extends both mean and maximal lifespan of mice fed a standard diet. This is accompanied by improvements in health, including enhanced motor coordination, performance, bone mineral density, and insulin sensitivity associated with higher mitochondrial content and decreased inflammation. Short-term SRT2104 treatment preserves bone and muscle mass in an experimental model of atrophy. These results demonstrate it is possible to design a small molecule that can slow aging and delay multiple age-related diseases in mammals, supporting the therapeutic potential of SIRT1 activators in humans.

SUBMITTER: Mercken EM 

PROVIDER: S-EPMC4172519 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2014-09-22 | E-GEOD-49000 | biostudies-arrayexpress
2014-09-22 | GSE49000 | GEO
| S-EPMC4244883 | biostudies-literature
| S-EPMC8045940 | biostudies-literature
| S-EPMC2784391 | biostudies-literature
| S-EPMC4010117 | biostudies-literature
| S-EPMC5784976 | biostudies-literature
2014-12-20 | E-GEOD-50987 | biostudies-arrayexpress